ArticleOPEN ACCESS

GlycoPEGylated factor IX: A new step forward

Blood
DOI: 10.1182/blood-2014-10-604983
1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Collins et al provide the results of a prospective, randomized, single-blind, phase 3 trial on the use of nonacog beta pegol, a new long-acting glycoPEGylated factor IX (FIX) molecule for the treatment and prevention of bleeding episodes in 74 patients with hemophilia B.

Cite

CITATION STYLE

APA

Mancuso, M. E. (2014, December 18). GlycoPEGylated factor IX: A new step forward. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2014-10-604983

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free